NCT00986869

Brief Summary

Background Flexible bronchoscopy (FB) is one of the most common invasive procedures performed by pulmonologists (1) . Typically performed under topical anesthesia and conscious sedation, the procedure is considered to be safe, effective and well tolerated in patients with a wide variety of pulmonary diseases (2). Complications associated with the procedure are rare and studies have estimated an incidence of 0.5-4% (3) The most commonly recognized complications include hypoxia, bleeding, bronchospasm, cardiac dysrhythmias, pneumothorax, and vagal reactions (4). Several conditions increase the risk of complications including pre-existent hypoxemia, use of mechanical ventilation, uremia, profound thrombocytopenia, coagulopathy and pulmonary hypertension (PH) (5). Although previous reports suggest that transbronchial biopsies increase the risk for hemorrhage in this population, data are is limited to survey analyses and isolated reports. Recently Guzman et al. reported a retrospective analysis about the safety of FB in PH. (6) They found that FB can be performed safely in patients with mild and moderate PH. However, the study was small and retrospective analysis. Furthermore, there is no consensus regarding levels of pulmonary artery pressure (PAP) considered to be safe for invasive diagnostic interventions such as TBLB or transbronchial needle aspiration. Objective To assess the safety of FB in patients with PH and to study the occurrence of complications associated with different diagnostic bronchoscopic procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

September 23, 2009

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 30, 2009

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

March 16, 2012

Status Verified

March 1, 2012

Enrollment Period

2.9 years

First QC Date

September 23, 2009

Last Update Submit

March 15, 2012

Conditions

Keywords

SafetyBronchoscopyPulmonaryHypertension

Outcome Measures

Primary Outcomes (1)

  • The primary outcome will be the incidence of complications after FB. Complications will define as hypoxemia, hypotension cardiac dysrhythmias, bleeding, and death.

    one year

Study Arms (1)

echocardiogram

All the patients will undergo a Doppler echocardiogram in the day of the bronchoscopy after the bronchoscopy

Procedure: Doppler echocardiogram

Interventions

All the patients will undergo a Doppler echocardiogram in the day of the bronchoscopy after the bronchoscopy

echocardiogram

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients that will undergo a bronchoscopy according to the regular indications during the study period (12 months) will be eligible for the study.

You may qualify if:

  • All patients that will undergo a bronchoscopy according to the regular indications during the study period (12 months) will be eligible for the study.

You may not qualify if:

  • Patients with known severe pulmonary hypertension (PAP above 70 mmHg) will be exclude from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Medical Center

Kfar Saba, Israel

RECRUITING

Related Publications (5)

  • Colt HG, Prakash UBS, Offord KP: Bronchoscopy in North America: survey by the American Association for Bronchology, 1999. J Bronchol 2000;7:8-25.

    BACKGROUND
  • Ernst A, Silvestri GA, Johnstone D; American College of Chest Physicians. Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest. 2003 May;123(5):1693-717. doi: 10.1378/chest.123.5.1693. No abstract available.

    PMID: 12740291BACKGROUND
  • Pue CA, Pacht ER. Complications of fiberoptic bronchoscopy at a university hospital. Chest. 1995 Feb;107(2):430-2. doi: 10.1378/chest.107.2.430.

    PMID: 7842773BACKGROUND
  • Pereira W Jr, Kovnat DM, Snider GL. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest. 1978 Jun;73(6):813-6. doi: 10.1378/chest.73.6.813.

    PMID: 657853BACKGROUND
  • Guidelines for fiberoptic bronchoscopy in adults. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1987 Oct;136(4):1066. doi: 10.1164/ajrccm/136.4.1066. No abstract available.

    PMID: 3662229BACKGROUND

MeSH Terms

Conditions

Hypertension, PulmonaryHypertension

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Michael kutuk

    Meir Medical Center

    STUDY CHAIR

Central Study Contacts

David Shitrit, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2009

First Posted

September 30, 2009

Study Start

September 1, 2009

Primary Completion

August 1, 2012

Study Completion

September 1, 2012

Last Updated

March 16, 2012

Record last verified: 2012-03

Locations